v3.25.1
Convertible Redeemable Preferred Stock and Stockholders' Equity - Part 4 (Details) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Sep. 26, 2024
Apr. 16, 2024
Feb. 14, 2024
Oct. 04, 2023
Jul. 31, 2023
May 31, 2023
May 09, 2023
Mar. 29, 2023
Aug. 31, 2025
Aug. 31, 2024
Jan. 31, 2024
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Oct. 31, 2024
Oct. 01, 2024
Oct. 03, 2023
Dec. 31, 2022
Convertible Redeemable Preferred Stock and Stockholders Equity [Line Items]                                    
Fixed commission rate               3.00%                    
Deferred offering costs (in Dollars)                         $ 366,113        
Warrants exercisable                         3,729          
Warrants outstanding fair value (in Dollars per share)                         $ 6.72          
Warrant liability (in Dollars)                         $ 43,089 2,641        
Proceeds from Warrant Exercises (in Dollars)                         6,155        
Contingent warrant liabilities (in Dollars)                         $ 32,892          
Settlement share                         39,158          
Reserved for issuance shares                                 142,749  
Fair value of stock options (in Dollars)                         $ 163 459        
Exercised price (in Dollars per share)         $ 43.6                          
Grant date fair value amount (in Dollars)       $ 200,000                            
Stock-based compensation expense (in Dollars)                         $ 438,653 $ 329,760        
Restricted shares granted           636 3,750                      
Restricted shares granted vest                   25.00% 50.00%              
Vesting period                         4 years          
Stock options outstanding   12,257                                
Expense (in Dollars)                         $ 18,000          
Weighted average exercise price (in Dollars per share)                             $ 3.46      
Warrant [Member]                                    
Convertible Redeemable Preferred Stock and Stockholders Equity [Line Items]                                    
Warrants exercisable                         583,475          
Series C PIPE Warrants [Member]                                    
Convertible Redeemable Preferred Stock and Stockholders Equity [Line Items]                                    
Warrant liability (in Dollars)                         $ 32,982          
Proceeds from Warrant Exercises (in Dollars)                         10,200          
Contingent warrant liabilities (in Dollars) [1]                         $ 32,892     $ 1,138,476    
Settlement share                         11,188          
Equity Option [Member]                                    
Convertible Redeemable Preferred Stock and Stockholders Equity [Line Items]                                    
Weighted average grant date fair value per share (in Dollars per share)                           $ 16.4        
Fair value of stock options (in Dollars)                         $ 700,000 $ 700,000        
Stock options granted                         406 1,148        
Stock-based compensation expense (in Dollars)                       $ 58,000 $ 58,000          
Stock option outstanding shares                         13,674 47,619       34,816
Weighted average exercise price (in Dollars per share)                         $ 156.96 $ 65.2       $ 132
2022 Plan [Member]                                    
Convertible Redeemable Preferred Stock and Stockholders Equity [Line Items]                                    
Reserved for issuance shares                       1,450,000            
Available shares                         719,660          
PMX Option Plan [Member]                                    
Convertible Redeemable Preferred Stock and Stockholders Equity [Line Items]                                    
Expected term                         11 years          
Stock option outstanding shares                             58,172      
At the Market Offering Agreement [Member]                                    
Convertible Redeemable Preferred Stock and Stockholders Equity [Line Items]                                    
Deferred offering costs (in Dollars)                         $ 300,000          
Other Current Liabilities [Member] | Series C PIPE Warrants [Member]                                    
Convertible Redeemable Preferred Stock and Stockholders Equity [Line Items]                                    
Contingent warrant liabilities (in Dollars)                         43,089          
Market Offering Agreement [Member]                                    
Convertible Redeemable Preferred Stock and Stockholders Equity [Line Items]                                    
Shares of common stock (in Dollars)               $ 3,900,000                    
Chief Executive Officer [Member]                                    
Convertible Redeemable Preferred Stock and Stockholders Equity [Line Items]                                    
Stock options granted       17,744                            
Exercised price (in Dollars per share)       $ 17.22                            
Stock-based compensation expense (in Dollars)                           $ 100,000        
Shares options of forfeited                           12,199        
Restricted shares granted             12,188                      
Chief Financial Officer [Member]                                    
Convertible Redeemable Preferred Stock and Stockholders Equity [Line Items]                                    
Restricted shares granted             3,750                      
CBO’s [Member]                                    
Convertible Redeemable Preferred Stock and Stockholders Equity [Line Items]                                    
Restricted shares granted             1,875                      
Board of Directors [Member]                                    
Convertible Redeemable Preferred Stock and Stockholders Equity [Line Items]                                    
Aggregate of stock options     78                              
Board of Directtors [Member[                                    
Convertible Redeemable Preferred Stock and Stockholders Equity [Line Items]                                    
Restricted stock (in Dollars) $ 16,590                                  
Expense (in Dollars)                         $ 18,000          
Common Stock [Member] | Onconetix Equity Incentive Plans [Member]                                    
Convertible Redeemable Preferred Stock and Stockholders Equity [Line Items]                                    
Reserved for issuance shares                       78,750            
Forecast [Member]                                    
Convertible Redeemable Preferred Stock and Stockholders Equity [Line Items]                                    
Restricted shares granted vest                 25.00%                  
August 2022 private placement [Member]                                    
Convertible Redeemable Preferred Stock and Stockholders Equity [Line Items]                                    
Warrant liability (in Dollars)                           $ 3,000        
IPO [Member]                                    
Convertible Redeemable Preferred Stock and Stockholders Equity [Line Items]                                    
Settlement share                         591,856          
[1] Included within Change in Fair Value of Contingent Warrant Liabilities in the accompanying consolidated statement of operations for the year ended December 31, 2024.